In this Healio Video Perspective, David A. Eichenbaum, MD, discusses data presented at the Retina Society meeting that looked at angiography and macular leakage in patients with diabetic macular edema.
The data were gathered from the YOSEMITE and RHINE studies and found a reduction in the area of angiographic leakage at 16 weeks in patients treated with faricimab compared with aflibercept, he said.